CPBIO Holding Company Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and...
CPBIO Sets August Board Meeting to Approve Interim Results and Consider Dividend
CPBIO expects 1H profit attributable to shareholders of about US$9.5 million, down from US$17 million
Chia Tai Enterprises International rebrands as CPBIO Holding Company
Chia Tai Group Surges 17% on AI Hardware Rally to Record High
Chia Tai Enterprises Sets May Board Meeting to Approve Q1 2026 Results
Chia Tai Enterprises to Build New RMB28.9 Million Fermentation Facility in Henan